Novel genetic and epigenetic alterations in ... - Ous-research.no

More documents

Recommendations

Info

Studies on p53, BAX and Bcl-2 protein expression and microsatellite instabilityin stage III (UICC) colon cancer treated by adjuvant chemotherapy: majorprognostic impact of proapoptotic BAX. Br J Cancer 96(9): 1409-141824. Gao J, Zhang H, Arbman G, Sun XF (2008) RAD50/MRE11/NBS1 proteins inrelation to tumour development and prognosis in patients with microsatellitestable colorectal cancer. Histol Histopathol 23(12): 1495-150225. Jung B, Doctolero RT, Tajima A, Nguyen AK, Keku T, Sandler RS, Carethers JM(2004) Loss of activin receptor type 2 protein expression in microsatelliteunstable colon cancers. Gastroenterology 126(3): 654-65926. Ionov Y, Matsui S, Cowell JK (2004) A role for p300/CREB binding protein genesin promoting cancer progression in colon cancer cell lines with microsatelliteinstability. Proc Natl Acad Sci U S A 101(5): 1273-127827. Comai L, Zomerdijk JC, Beckmann H, Zhou S, Admon A, Tjian R (1994)Reconstitution of transcription factor SL1: exclusive binding of TBP by SL1 orTFIID subunits. Science 266(5193): 1966-197228. Gorski JJ, Pathak S, Panov K, Kasciukovic T, Panova T, Russell J, Zomerdijk JC(2007) A novel TBP-associated factor of SL1 functions in RNA polymerase Itranscription. EMBO J 26(6): 1560-156829. Jung BH, Beck SE, Cabral J, Chau E, Cabrera BL, Fiorino A, Smith EJ, Bocanegra M,Carethers JM (2007) Activin type 2 receptor restoration in MSI-H colon cancersuppresses growth and enhances migration with activin. Gastroenterology 132(2):633-64430. Helleday T, Lo J, van G, Engelward BP (2007) DNA double-strand break repair:from mechanistic understanding to cancer treatment. DNA Repair (Amst) 6(7):923-93531. Lothe RA, Peltomäki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L,Heimdal K, Andersen TI, Moller P, Rognum TO, . (1993) Genomic instability incolorectal cancer: relationship to clinicopathological variables and familyhistory. Cancer Res 53(24): 5849-585232. Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, SkotheimRI, Thiis-Evensen E, Lothe RA. Gene methylation profiles of normal mucosa, andbenign and malignant colorectal tumors identify early onset markers. Molecularcancer. In press33. Kim NG, Rhee H, Li LS, Kim H, Lee JS, Kim JH, Kim NK, Kim H (2002)Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genesin colorectal carcinomas with microsatellite instability. Oncogene 21(33): 5081-508726
34. Martineau-Thuillier S, Andreassen PR, Margolis RL (1998) Colocalization of TD-60and INCENP throughout G2 and mitosis: evidence for their possibleinteraction in signalling cytokinesis. Chromosoma 107(6-7): 461-47035. Mollinari C, Reynaud C, Martineau-Thuillier S, Monier S, Kieffer S, Garin J,Andreassen PR, Boulet A, Goud B, Kleman JP, Margolis RL (2003) The mammalianpassenger protein TD-60 is an RCC1 family member with an essential role inprometaphase to metaphase progression. Dev Cell 5(2): 295-30736. Rosasco-Nitcher SE, Lan W, Khorasanizadeh S, Stukenberg PT (2008) CentromericAurora-B activation requires TD-60, microtubules, and substrate primingphosphorylation. Science 319(5862): 469-47237. Hughes TA (2006) Regulation of gene expression by alternative untranslatedregions. Trends Genet 22(3): 119-12238. Pickering BM, Willis AE (2005) The implications of structured 5' untranslatedregions on translation and disease. Semin Cell Dev Biol 16(1): 39-4739. Wilkie GS, Dickson KS, Gray NK (2003) Regulation of mRNA translation by 5'-and 3'-UTR-binding factors. Trends Biochem Sci 28(4): 182-18840. Suraweera N, Iacopetta B, Duval A, Compoint A, Tubacher E, Hamelin R (2001)Conservation of mononucleotide repeats within 3' and 5' untranslated regionsand their instability in MSI-H colorectal cancer. Oncogene 20(51): 7472-747727
Page 1 and 2:
Novel genetic and epigenetic altera
Page 3 and 4:
TABLE OF CONTENTSACKNOWLEDGEMENTS .
Page 5 and 6:
ACKNOWLEDGEMENTSThe present work ha
Page 7 and 8:
Prefacetechnology[3]. This new tech
Page 10 and 11:
SummaryThe subgroup of carcinomas w
Page 12 and 13:
Introduction“Epigenetic inheritan
Page 14 and 15:
Introductionamino acid change it is
Page 16 and 17:
Introductionmethylation during embr
Page 18 and 19:
IntroductionDNA is most of the time
Page 20 and 21:
IntroductionFigure 5. DNA methylati
Page 22 and 23:
IntroductionFigure 6. Incidence rat
Page 24 and 25:
IntroductionFigure 8. Tumor staging
Page 26 and 27:
Introductioninasmuch as 80% of colo
Page 28 and 29:
IntroductionInstabilities involved
Page 30 and 31:
Introductionthere seems to be a fid
Page 32 and 33:
Introductionsevere alterations are
Page 34 and 35:
Introductionpopulation-wide screeni
Page 36 and 37:
IntroductionFigure 12. Present and
Page 38 and 39:
RESULTS IN BRIEFPaper Ia. “DNA hy
Page 40 and 41:
Results in Briefinstability, and se
Page 42 and 43:
Results in BriefUnivariate survival
Page 44 and 45:
Discussionseveral factors, and full
Page 46 and 47:
Discussionlow threshold, we increas
Page 48 and 49:
DiscussionIt may seem like unnecess
Page 50 and 51:
Discussionthan 96% DHPLC do not sta
Page 52 and 53:
DiscussionFigure 13. Mutation detec
Page 54 and 55:
DiscussionClinical impact of molecu
Page 56 and 57:
Discussionmarkers with a very high
Page 58 and 59:
Discussionchromosomes in metaphase[
Page 60 and 61:
DiscussionThese examples underline
Page 62 and 63:
Discussiongenes. One is based on mu
Page 64 and 65:
CONCLUSIONSWe have identified novel
Page 66 and 67:
Future PerspectivesMolecular risk a
Page 68 and 69:
REFERENCES1. Breasted J (1930) The
Page 70 and 71:
References29. Deng G, Chen A, Pong
Page 72 and 73:
References57. Al-Sukhni W, Aronson
Page 74 and 75:
References84. Kunkel TA (1993) Nucl
Page 76 and 77:
ReferencesLeggett B, Levine J, Kim
Page 78 and 79:
References133. Lind GE, Thorstensen
Page 80 and 81:
References156. Meling GI, Lothe RA,
Page 82 and 83:
ReferencesT, Song X, Day RH, Sledzi
Page 84 and 85:
References196. Honda S, Haruta M, S
Page 86 and 87:
ORIGINAL ARTICLESAPPENDIXAppendix I
Page 89 and 90:
GASTROENTEROLOGY 2007;132:1631-1639
Page 91:
Paper IbGuro E Lind, Terje Ahlquist
Page 94 and 95:
Journal of Translational Medicine 2
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 105: Paper IITerje Ahlquist, Guro E Lind
Page 108 and 109: BackgroundMost cases of colorectal
Page 110 and 111: ADAMTS1 CDKN2A CRABP1 HOXA9 MAL MGM
Page 112 and 113: pseudogene, leading to a high rate
Page 114 and 115: strands. Proc Natl Acad Sci U S A 1
Page 116 and 117: concomitant absence of transcript a
Page 119 and 120: Volume 10 Number 7 July 2008 pp. 68
Page 121 and 122: 682 RAS Signaling in Colorectal Car
Page 127: Table W2. Detailed Somatic Events o
Page 131 and 132: Identification of RCC2 as a prognos
Page 133 and 134: INTRODUCTIONMicrosatellite instabil
Page 135 and 136: unselected series of primary tumors
Page 137 and 138: specificity, i.e. that they only am
Page 139 and 140: On the assumption that DNA repair a
Page 141 and 142: In order to ensure that gene mutati
Page 143 and 144: Figure 2. Mutation frequency differ
Page 145 and 146: and TAF1B (0.50), ACVR2A and ASTE1
Page 147 and 148: Multivariate analysesA multivariate
Page 149 and 150: When comparing our findings of muta
Page 151 and 152: The test series included a low numb
Page 153 and 154: entering M-phase remains to be seen
Page 155: 12. Duval A, Reperant M, Hamelin R
Page 159: AppendicesAppendix I:List of abbrev
Page 163 and 164: Critical Reviews TM in Oncogenesis,
Page 165 and 166: TARGET GENES OF MSI COLORECTAL CANC
Page 191: TARGET GENES OF MSI COLORECTAL CANC
show all

Novel genetic and epigenetic alterations in ... - Ous-research.no

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?